Induction of experimental allergic encephalomyelitis is facilitated in a genetically resistant BALB/c mouse strain by a nonpathogenic strain of a neurotropic alphavirus, Semliki Forest virus (SFV-A7). One possible explanation for this enhancement is virus infection of endothelial cells (EC), causing increased permeability of the blood-brain barrier. We have now sought evidence for virus infection of EC in vivo by immunocytochemistry and in situ hybridization. SFV-A7 antigens and RNA were detected in vascular EC and perivascular neurons in cerebellar and spinal cord white matter. Expression of viral antigens was followed by fibrinogen leakage from the blood vessels into brain parenchyma. is facilitated in a genetically resistant mouse strain, BALB/c, by infection with an avirulent mutant of a neurotropic alphavirus, Semliki Forest virus (SFV-A7) (7), 7 days after the induction of EAE (44). However, the mechanisms by which the virus facilitates EAE in BALB/c mice have not been established.
Induction of experimental allergic encephalomyelitis is facilitated in a genetically resistant BALB/c mouse strain by a nonpathogenic strain of a neurotropic alphavirus, Semliki Forest virus (SFV-A7). One possible explanation for this enhancement is virus infection of endothelial cells (EC), causing increased permeability of the blood-brain barrier. We have now sought evidence for virus infection of EC in vivo by immunocytochemistry and in situ hybridization. SFV-A7 antigens and RNA were detected in vascular EC and perivascular neurons in cerebellar and spinal cord white matter. Expression of viral antigens was followed by fibrinogen leakage from the blood vessels into brain parenchyma. This was shown by immunoperoxidase staining detecting fibrinogen extravascularly in central nervous system sections of infected mice. Simultaneously, expression of ICAM-1 (intercellular adhesion molecule 1) was induced on brain EC. SFV-A7 replicated in mouse brain microvascular EC in vitro and caused lysis of the cells. SFV-A7 did not induce ICAM-1 expression of mouse brain microvascular EC in vitro, while ICAM-1 was readily induced by gamma interferon and interleukin 1I. The observed increase of ICAM-1 expression on EC is immune mediated and not a direct effect of the virus infection. We conclude that SFV-A7 infection causes cerebral microvascular damage which contributes to the facilitation of experimental allergic encephalomyelitis in BALB/c mice.
Relapse phases of multiple sclerosis (MS) are associated with viral infections (3, 37) , but it is not known how virus infections modulate this autoimmune demyelinating disease. Blood-brain barrier (BBB) damage caused by virus infection is one possible mechanism, since increased BBB permeability is an early and possibly crucial event in the pathogenesis of new lesions in MS (22) and some viral infections are also known to cause vascular permeability changes. Vascular injury is a central feature of some hemorrhagic fevers (10, 35) , and BBB damage has been shown during human immunodeficiency virus encephalitis (29) and uncomplicated measles virus infection (19) .
It is largely unknown whether the increased vascular permeability during virus infection is caused by virus replication in endothelial cells (EC), virus-induced cytokines, anti-EC antibodies raised during the virus infection, or other yet unknown mechanisms (41) . Several common viruses such as herpes simplex, mumps, and measles viruses and many enteroviruses are able to infect cultured EC derived from either human umbilical vein or dermal microvessels (1, 14) . Although susceptibility in vitro does not confer susceptibility in vivo, many of these viruses have been shown to infect human or animal EC also in vivo (5, 18, 42, 43) . Whether infection of EC by these common viruses in vivo leads to increased vascular permeability is not well known.
Experimental allergic encephalomyelitis (EAE) is an animal model in which a clinically and histologically MS-like disease is induced in susceptible strains of laboratory animals by active immunization with neuroantigen in complete Freund's adjuvant or by transfer of T cells specific for brain antigens (26). We have earlier described an EAE model in which the disease infection with an avirulent mutant of a neurotropic alphavirus, Semliki Forest virus (SFV-A7) (7), 7 days after the induction of EAE (44) . However, the mechanisms by which the virus facilitates EAE in BALB/c mice have not been established.
Adhesion molecules have been shown to have a central role in recruitment of leukocytes into the central nervous system (CNS) during inflammation. Induction of intercellular adhesion molecule 1 (ICAM-1) in inflammation is an important means of regulating leukocyte-EC interactions (39) . Increased influx of inflammatory cells into the CNS correlates with upregulation of ICAM-1 in mouse EAE (9) , and initiation of BBB damage in MS correlates with increased levels of circulating ICAM-1 in the serum and in the cerebrospinal fluid of MS patients (36) . Increased cytokine-induced expression of ICAM-1 on cultured murine cerebrovascular EC results in increased adhesion of myelin basic protein-specific encephalitogenic T cells to the EC (25) . In addition, antibodies to ICAM-1 have been shown to inhibit EAE in Lewis rats (4) . Virus infection may also have an effect on the expression of adhesion molecules. Induction of ICAM-1 has been described during herpes simplex virus encephalitis in humans (38) , and increased expression of vascular cell adhesion molecule 1 on brain vessels has been shown in macaque simian immunodeficiency virus encephalitis (34) .
In this report, we extend our earlier studies of facilitation of BALB/c mouse EAE by SFV-A7. Since For detection of ICAM-1, 6-,um frozen sections from infected and control mice were stained with diluted Y.N./1.7.4. hybridoma supernatant reactive with murine ICAM-1. The Vectastain anti-rat antibody staining kit was used to demonstrate binding of the primary antibody.
In situ hybridization. The SFV-A7 probe was from the El region of the viral genome, corresponding to the nucleotides 10658 to 10953 of the wild-type virus cDNA. The probe DNA was released by digestion with EcoRI from a clone, prepared by PCR from SFV-A7 cDNA, and purified from the vector (pCRII; In vitrogen) by electrophoresis through an agarose gel. The DNA was eluted from agarose by use of agarase enzyme (Boehringer Mannheim). The fragment was labeled with digoxigenin (DIG)-11-dUTP by random priming with the DIG DNA labeling and detection kit (Boehringer Mannheim), as described previously (21) .
Sections of formalin-fixed, paraffin-embedded mouse CNS tissue were cut at a 5-,um thickness and mounted on organosiliconized slides (24) . Sections from uninfected mice as well as MBA-13 cells, uninfected or infected with SFV-A7 (10 PFU per cell) and harvested at 8 h postinfection, were used as hybridization controls. The in situ hybridization was done as described previously for DIG DNA probes (21) , and it involved a prehybridization step using 300 ,ug of denatured salmon sperm DNA per ml and the use of mouse brain nucleic acids (500 ,ug/ml) as a blocking agent in the hybridization buffer. The hybridization took place for 21 h at +42°C under sealed caps in a humidified incubator. The slides were washed as described in reference 33 and subjected to the nonradioactive detection protocol (21) . Briefly, the sections were incubated in 1% blocking reagent of the DIG DNA labeling and detection kit for 30 min at +20°C, incubated with the alkaline phosphatase-conjugated anti-DIG antibody (750 mU/ml) in a humid chamber for 30 min at +20°C, and washed and incubated with the nitroblue tetrazolium-X-phosphate color reagents in a dark, humidified chamber for 8 to 16 h. The slides were stained slightly with hematoxylin-eosin or eosin only, and the coverslips were mounted with Gurr's Aquamount. The slides were observed in a blinded fashion.
Culture of MBMEC. MBMEC were isolated and cultured according to the method described by L. de Bault et al. (11) with some modifications. Briefly, 10 BALB/c mouse pups were killed by cervical dislocation, and their brains were aseptically removed, washed in isolation medium (Dulbecco modified Eagle medium, 25 mM HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid], 100 IU of penicillin per ml, 100 jig of streptomycin per ml, and 1 jig of amphotericin B [Fungizone] per ml = medium A), mechanically homogenized, and sequentially filtered through 145-and 55-jim nylon screens. The material retained on 55-p.m screens was spun for 10 min at 1,000 x g on 50% Percoll gradients prepared as described by Goldstein et al. (16) Plaque titration. Serial 10-fold dilutions of the collected, cell-free supernatants were inoculated in duplicate 100-ptl volumes onto MBA-13 cells grown in 12-well tissue culture plates. After the virus was allowed to adhere for 1 h, medium containing three parts of 2% modified Eagle medium and one part of 4% carboxymethyl cellulose and 2x Hanks salt solution was gently added to the wells. After 48 h of incubation, the medium was removed, the cell layer was stained with 2% crystal violet, and the plaques were counted.
Immunocytochemistry of infected cells. MBMEC were grown on glass coverslips, infected with SFV-A7 as described above, and harvested for immunofluorescence at six time points between 6 and 72 h postinfection (p.i.). The coverslips were washed with PBS, fixed in cold acetone, and incubated with rabbit polyclonal antiserum to SFV-A7 for 1 h at 24°C in a moist chamber; washed three times with PBS; and incubated for 30 min with goat antiserum to rabbit IgG conjugated with lissamine-rhodamine. After a further washing cycle, the cells were incubated with GSA-FITC for 1 h, washed, air dried, and mounted in Fluoromount (BDH Ltd., Poole, England).
RESULTS
Detection of SFV-A7 antigens in vivo. To reveal whether mouse brain EC are infected after intraperitoneal infection of mice with SFV-A7, brain sections of infected and control mice were stained for SFV antigens with specific rabbit antiserum. Viral antigens were found in vascular EC, neuronal cell bodies, axons, and dendrites of cerebral hemispheres, cerebellum, and spinal cord. The virus antigens first appeared on day 2, peaked on day 4, and disappeared after day 7 p.i. (Fig. 1A) . The lesions were focally distributed throughout the CNS and concentrated around small blood vessels. Positive staining appeared first and was most abundant in cerebellar and pons white matter. Control mice were negative.
To differentiate EC from astrocytes, perivascular microglia, or pericytes, double labeling with rabbit anti-human FVIII antibodies and mouse SFV-A7-specific antiserum was done on frozen CNS sections. Light microscopy ( Fig. 2B ) and confocal microscopy (not shown) showed expression of viral antigens in cells identified as EC with the typical granular pattern of FVIII staining ( Fig. 2A) .
BBB damage closely correlating with the regional and chronological distribution of the spread of the virus in the brain was shown by detecting fibrinogen in the brain parenchyma of infected mice (Fig. 1B) . In uninfected mice, no fibrinogen was found outside the blood vessels.
Detection of viral RNA by in situ hybridization. In order to characterize the distribution of viral RNA in tissues, CNS sections of infected and control mice were hybridized in situ with a nonradioactive probe from the El region of the viral genome. An average total of 29 CNS tissue sections from two mice were examined for each time point of infection. Three uninfected mice were included as hybridization controls. SFV-A7 RNA was observed in capillary EC and in neuronal cell bodies in cerebellum, midbrain, spinal cord, and cerebral hemispheres (Fig. 3) . Cells reactive with the A7 probe were first detected on day 1 after the virus inoculation ( Table 1 ). The number of cells reactive with the probe was highest on days 3 to 4 p.i., decreasing to less than one positive cell per section by day 7 p.i. The cells positive for A7 RNA appeared typically in foci surrounding small blood vessels in the CNS. The SFV-A7 RNA-positive EC were observed on days 1 to 4 p.i. The MBA-13 cells, infected in culture with SFV-A7, were strongly positive for the probe at 8 h p.i.
ICAM-1 expression in vivo. To study whether expression of an inducible adhesion receptor, ICAM-1, is enhanced during the course of CNS inflammation caused by SFV-A7 infection, immunoperoxidase staining for ICAM-1 on SFV-A7-infected and control brains was done. In brain tissue of normal, 6-to 8-week-old female BALB/c mice, expression of ICAM-1 was low with a faint staining only on a few vessels (Fig. 1C) . sels and their intensity of staining increased from day 3 p.i., peaked on days 5 to 6 (Fig. 1D) , and thereafter gradually declined to the basal low level. The expression correlated with the mononuclear cell infiltration identified in immunohistochemical staining for T-cell and monocyte cell surface antigens (data not shown). Simultaneously, appearance of viral antigens in CNS on and around blood vessels was observed (Fig. 1A) and was followed by leakage of fibrinogen from the vessels into brain parenchyma (Fig. 1B) .
Culture and characterization of MBMEC. To study whether the observed induction of ICAM-1 during SFV-A7 infection was directly caused by the virus and whether virus antigen expression on and around vascular EC was associated with cell injury, we set up a system for culturing mouse brain capillary EC in vitro. When EC are prepared from mouse brain, it is essential to verify that the culture is homogeneous for these cells. The reason for this is that the isolation procedure may trap other cell types, such as smooth muscle cells or astrocytes. The marker we used to identify EC was FITC-coupled Griffonia simplicifolia, a lectin detecting EC of mouse origin. In addition, the MBMEC were tested for the ability to uptake acetylated LDL (DiI-Ac-LDL), a function mediated by specific receptors typically found on EC. The EC used were from the second or third passage and showed positive staining with GSA-FITC (Fig. 4A) residues of the lectin conjugate were blocked with 2 mM D(+)-galactose. The MBMEC showed a strong accumulation of DiI-Ac-LDL, unlike MBA-13 cells, a transformed mouse brain cell line, which served as a negative control. Astrocyte contamination was minimal as shown by fewer than 1% of the cells staining positively with rabbit anti-human glial fibrillary acidic protein (data not shown).
Replication of SFV-A7 in MBMEC. To study the replication of SFV-A7 in MBMEC, indirect immunofluorescence staining for virus antigens was first done with specific antiserum. The experiment revealed that by 24 h (after three to four cycles of virus replication) almost all of the cells were infected and that by 72 h all of them were lysed. Double immunofluorescence confirmed the endothelial origin of the infected cells (Fig. 4) . The infection was productive, as shown by an increase in virus titer peaking at 11 to 24 h p.i. (Fig. 5) .
ICAM 
DISCUSSION
We have shown that infection by a nonpathogenic mutant of SFV (SFV-A7) in mice leads to expression of viral nucleic acids and antigens on brain vascular EC and in perivascular neurons. Leakage of fibrinogen occurred at areas with viral antigens. Increased ICAM-1 expression in the brain during SFV infection correlated with the mononuclear cell infiltration. Virus infection of mouse brain EC with the same strain in vitro led to production of infectious virus, but no increase in ICAM-1 expression was observed.
SFV-A7 virus infection in mouse EC in vitro caused lytic infection. Similar EC damage has been described for some other virus infections. Marburg virus, the cause of a fulminating form of hemorrhagic fever, has been shown to replicate in human umbilical vein EC and in organ culture of human umbilical veins to high titers, causing partial EC lysis. It has been suggested that viral damage to the endothelial integrity is a primary pathogenic mechanism in this virus-induced hemorrhagic disease (35) . The etiological agent of Korean hemorrhagic fever, Hantaan virus, has also been shown to replicate in human umbilical vein EC but without any obvious cytopathic effect (28) .
The EC injury leads to increased fluid permeability (30) . We showed increased cerebral vascular leakiness during SFV-A7 infection by detecting fibrinogen in the extravascular space of the brain in areas with virus antigen. As fibrinogen is a serum protein which does not pass intact BBB (31) It has been suggested earlier that SFV enters into the brain from the blood by passage across cerebral EC as studied by electron microscopy (27) . Recently, in situ hybridization and autoradiographic studies showed SFV-A7 and wild-type virus infection in the CNS as scattered, perivascular foci (13) . Our results demonstrating SFV-A7 replication in mouse brain EC in vitro and infection of EC in vivo strongly favor this hypothesis. Viral replication within capillary EC could lead to cytolysis, EC damage, and virus dissemination into the brain parenchyma.
Virus infection of the brain EC may have also other consequences. Vascular leakiness diminishes the shear force provided by flowing blood moving parallel to the EC surface. Diminished shear force favors leukocyte adherence to the EC surface (30) . Thus, the direct EC damage caused by SFV-A7 infection of EC could be a mechanism for leukocyte recruitment into the CNS in murine SFV-A7 infection, during which marked infiltrates of immune cells can be seen in histochemical staining of brain and spinal cord tissue although the animals remain asymptomatic (6) .
Reduction in shear force acts in concert with concomitant increase in the leukocyte-EC adhesive interactions (30) . The molecular basis of increased leukocyte-EC adhesiveness during inflammation has been under extensive investigation during the past few years. It is now apparent that there are inducible adhesion molecules both on leukocyte and on EC surfaces and that the interaction during the adhesion and transmigration process is dynamic, such that the relevant molecules change as the process proceeds (8) . Our results indicate that ICAM-1 is induced during SFV-A7 infection following appearance of viral antigens in CNS. However, infection of mouse brain EC by SFV-A7 in vitro did not cause increased cell surface expression of ICAM-1, whereas its expression was induced by gamma interferon and interleukin-l, in accordance with earlier reports (12) . We suggest that the induction of ICAM-1 expression during SFV-A7 infection in vivo is caused by cytokines secreted by the infiltrating mononuclear cells. Increased ICAM-1 expression on brain vessels could contribute to increased binding of mononuclear cells, providing a mechanism for recruitment of more inflammatory cells into CNS.
We have initiated these studies on SFV-A7 infection in mouse brain EC because this virus enhances development of EAE in the BALB/c mouse (44) . Disease activity in chronic relapsing EAE of guinea pigs has been shown to correlate with BBB damage (20) demonstrated by gadolinium-enhanced nuclear magnetic imaging (20) . Similarly, foci of BBB leakage have been shown to be the earliest detectable change in the CNS of patients with MS (22) . BBB leakage of plasma proteins has also been demonstrated by immunocytological methods from postmortem samples of recently active MS cases (15) . Virus infections have been shown to induce relapse phases of MS (3, 37) . BBB damage or increased expression of adhesion molecules caused by the virus infection could be possible mechanisms of the observed association, since vascular permeability changes are a central feature of certain virus infections (10, 29) and induction of vascular endothelial adhesion molecules has been shown during viral encephalitis in humans and in monkeys (34, 38) . In this report, we show that SFV-A7 infection causes increased ICAM-1 expression in the brain and increased BBB permeability. This could lead to increased adhesion of leukocytes to brain EC and thus facilitate the entry of inflammatory cells into the brain in mice infected with SFV-A7 after challenge with spinal cord homogenate. This could lead to earlier appearance of EAE signs and symptoms and larger proportion of affected BALB/c mice in EAE with SFV-A7 infection than without viral facilitation. We suggest that facilitation of leukocyte entry to the CNS is a major mechanism for EAE facilitation in the BALB/c mouse by SFV-A7.
In conclusion, an avirulent mutant of a neurotropic SFV, SFV-A7, causes both direct and immune-mediated injury to murine cerebrovascular EC. This could be one mechanism of viral facilitation of EAE. Whether common virus infections are capable of causing hitherto-unrevealed cerebral vascular permeability alterations or inducing adhesion molecules on brain vascular EC in MS patients is a challenging question remaining to be investigated.
